Immunotherapy has revolutionized the treatment landscape for solid tumors, achieving remarkable success in some patients while others show variable ...
A new study uncovers how a novel immunotherapy prevents squamous cell carcinoma, with benefits lasting five years after treatment. This therapy is the first to activate specific components of the ...